Nephros, Inc. (NASDAQ:NEPH) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Kirin Smith - PCG Advisory Robert Banks - CEO Judy Krandel - Chief Financial Officer Andy Astor - Advisor and Interim CFO Conference Call Participants Thomas McGovern - Maxim Group Operator Good afternoon and welcome to the Nephros Inc. Third Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation there will be ...

OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: _______ to _______ Commission File Number: 001-32288 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2023 NEPHROS, INC. (Exact name of registrant as specified in its charter) DELAWARE 13-3971809 (State or o ...

Nephros, Inc. (NASDAQ:NEPH) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Kirin Smith - PCG Advisory Robert Banks - CEO Andy Astor - Advisor and Interim CFO Conference Call Participants Thomas McGovern - Maxim Group Robert Smith - Center for Performance Investing Operator Good afternoon, everyone, and welcome to the Nephros Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the c ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: _______ to _______ Commission File Number: 001-32288 NEPHROS, INC. Indicate by check mark whether the registrant: (1) has filed all reports required to be fil ...

Nephros, Inc. (NASDAQ:NEPH) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Kirin Smith - PCG Advisory Andy Astor - President & Chief Executive Officer Robert Banks - Upcoming President & Chief Executive Officer Conference Call Participants Nick Sherwood - Maxim Group Operator Good afternoon, everyone, and welcome to the Nephros Incorporated. First Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please also note, that today’s event is being recorded. And ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2023 DELAWARE 13-3971809 (State or other jurisdiction of incorporation or organization) 380 Lackawanna Place South Orange, NJ 07079 (Address of principal executive offices) (Zip Code) (201) 343-5202 Registrant's telephone number, including area code OR ☐ TRANSITION REPORT PURSUANT TO SEC ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-32288 NEPHROS, INC. (Exact name of registrant specified in its charter) (State or Other Jurisdiction of Incorporation or Organization) Delaware 13-39 ...

Nephros, Inc. (NASDAQ:NEPH) Q4 2022 Earnings Conference Call March 8, 2023 4:30 PM ET Company Participants Kirin Smith - PCG Advisory Andrew Astor - President and CEO Conference Call Participants Anthony Vendetti - Maxim Group Joseph Schuler - JAS Investors Operator Good afternoon, and welcome to the Nephros Inc. Fourth Quarter 2022 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Kirin Smith, Investor Relat ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: _______ to _______ Commission File Number: 001-32288 NEPHROS, INC. (Exact name of registrant as specified in its charter) DELAWARE 13-3971809 (State or o ...

Nephros, Inc. (NASDAQ:NEPH) Q3 2022 Earnings Conference Call November 2, 2022 4:30 PM ET Company Participants Kirin Smith - PCG Advisory Andrew Astor - President and CEO Conference Call Participants Marc Wiesenberger - B. Riley Securities Paul Resnik - Resnik Asset Management Operator Good day, everyone, and welcome to the Nephros, Inc. Third Quarter 2022 Financial Results Conference Call. [Operator Instructions]. At this time, I'd like to turn the floor over to Kirin Smith with PCG Advisory. Please go ahea ...